EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Undetectable anti‐Mullerian hormone and inhibin B do not preclude the presence of germ cell tumours in 45,X/46,XY or 46,XY gonadal dysgenesis

Sabine E Hannema iD, Katja P Wolffenbuttel, Yolande van Bever, Hennie T Brüggenwirth, Sjoerd A A van den Berg, Remko Hersmus, J Wolter Oosterhuis, Leendert H J Looijenga

Clinical Endocrinology · 2023

DOI: 10.1111/cen.14909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, 2023. Verfasst von Sabine E Hannema und 7 weiteren Autor:innen. Beteiligte Einrichtung: Erasmus MC, Sophia Children's Hospital, DSD-Expert Center, University Medical Center Rotterdam, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Gonadoblastoma, Dysgerminoma, Gonadal Dysgenesis, 46,XY, Neoplasms, Germ Cell and Embryonal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Individuals with 45,X/46,XY or 46,XY gonadal dysgenesis are at increased risk of germ cell malignancies. Therefore, prophylactic bilateral gonadectomy is advised in girls and considered in boys with atypical genitalia for undescended, macroscopically abnormal gonads. However, severely dysgenetic gonads may not contain germ cells rendering gonadectomy unnecessary. Therefore, we investigate if undetectable preoperative serum anti‐Müllerian hormone (AMH) and inhibin B can predict the absence of germ cells, (pre)malignant or otherwise. Design, Patients and Measurements Individuals who had undergone bilateral gonadal biopsy and/or gonadectomy because of suspected gonadal dysgenesis in 1999–2019 were included in this retrospective study if preoperative AMH and/or inhibin B were available. Histological material was reviewed by an experienced pathologist. Haematoxylin and eosin and immunohistochemical stainings for SOX9, OCT4, TSPY and SCF (KITL) were used.

Results

Thirteen males and 16 females were included, 20 with 46,XY and 9 with 45,X/46,XY DSD. Three females had dysgerminoma alongside gonadoblastoma; two gonadoblastoma, one germ cell neoplasia in situ (GCNIS) and three males had pre‐GCNIS and/or pre‐gonadoblastoma. Gonadoblastoma and/or dysgerminoma were present in 3/11 individuals with undetectable AMH and inhibin B, one of whom also had non‐(pre)malignant germ cells. Of the other 18, in whom AMH and/or inhibin B were detectable, only one had no germ cells.

Conclusions

Undetectable serum AMH and inhibin B cannot reliably predict the absence of germ cells and germ cell tumours in individuals with 45,X/46,XY or 46,XY gonadal dysgenesis. This information should help in counselling about prophylactic gonadectomy, taking into account both the germ cell cancer risk and potential for gonadal function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GonadoblastomaDysgerminomaGonadal Dysgenesis, 46,XYNeoplasms, Germ Cell and EmbryonalGonadal DysgenesisOvarian NeoplasmsMaleFemaleHumansAnti-Mullerian HormoneRetrospective StudiesInhibins

Stichwörter der Autor:innen

46,XY DSDanti-Mullerian hormonegerm cell cancergerm cellsinhibinsex chromosome DSD

Substanzen

Anti-Mullerian Hormoneinhibin BInhibins

Autor:innen und Institutionen

  • Erasmus MC, Sophia Children's Hospital, DSD-Expert Center, University Medical Center Rotterdam, Rotterdam, the Netherlands.
  • Department of Pediatric Endocrinology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
  • Department of Pediatrics, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Paediatric Endocrinology, Amsterdam University Medical Centers, location Vrije Universiteit, Amsterdam, the Netherlands.
  • Department of Urology and Pediatric Urology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
  • Department of Clinical Genetics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.

ORCID-Profile: Sabine E Hannema

Zitieren

APA

Hannema, S. E., Wolffenbuttel, K. P., van Bever, Y., Brüggenwirth, H. T., van den Berg, S. A. A., Hersmus, R., Oosterhuis, J. W., & Looijenga, L. H. J. (2023). Undetectable anti‐Mullerian hormone and inhibin B do not preclude the presence of germ cell tumours in 45,X/46,XY or 46,XY gonadal dysgenesis. Clinical Endocrinology. https://doi.org/10.1111/cen.14909

Vancouver

Hannema SE, Wolffenbuttel KP, van Bever Y, Brüggenwirth HT, van den Berg SAA, Hersmus R, et al. Undetectable anti‐Mullerian hormone and inhibin B do not preclude the presence of germ cell tumours in 45,X/46,XY or 46,XY gonadal dysgenesis. Clinical Endocrinology. 2023. doi:10.1111/cen.14909

BibTeX
@article{Hannema2023,
  author = {Hannema, Sabine E and Wolffenbuttel, Katja P and van Bever, Yolande and Brüggenwirth, Hennie T and van den Berg, Sjoerd A A and Hersmus, Remko and Oosterhuis, J Wolter and Looijenga, Leendert H J},
  title = {Undetectable anti‐Mullerian hormone and inhibin B do not preclude the presence of germ cell tumours in 45,X/46,XY or 46,XY gonadal dysgenesis},
  journal = {Clinical Endocrinology},
  year = {2023},
  doi = {10.1111/cen.14909}
}
Kostenlos starten →